These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 18221172)
1. Structural development, haematological immunological and pharmacological effects of quinolones. Chide OE; Orisakwe OE Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):157-68. PubMed ID: 18221172 [TBL] [Abstract][Full Text] [Related]
2. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin. Kocsis B; Domokos J; Szabo D Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369 [TBL] [Abstract][Full Text] [Related]
3. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
4. Development of the quinolones. Andersson MI; MacGowan AP J Antimicrob Chemother; 2003 May; 51 Suppl 1():1-11. PubMed ID: 12702698 [TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone adverse effects and drug interactions. Fish DN Pharmacotherapy; 2001 Oct; 21(10 Pt 2):253S-272S. PubMed ID: 11642691 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of antimicrobial agents. 3. Syntheses and antibacterial activities of 7-(4-hydroxypiperazin-1-yl)quinolones. Uno T; Kondo H; Inoue Y; Kawahata Y; Sotomura M; Iuchi K; Tsukamoto G J Med Chem; 1990 Oct; 33(10):2929-32. PubMed ID: 2170653 [TBL] [Abstract][Full Text] [Related]
7. Recent developments of quinolone-based derivatives and their activities against Escherichia coli. Gao F; Wang P; Yang H; Miao Q; Ma L; Lu G Eur J Med Chem; 2018 Sep; 157():1223-1248. PubMed ID: 30193220 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety. Emami S; Foroumadi A; Faramarzi MA; Samadi N Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000. Phillips OA; Matowe WC Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651 [TBL] [Abstract][Full Text] [Related]
16. Heterocyclic urea derivatives and methods of use thereof (WO2010142978). Supuran CT; Scozzafava A Expert Opin Ther Pat; 2012 Feb; 22(2):193-7. PubMed ID: 22264034 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-mycobacterial activities of triazoloquinolones. Carta A; Palomba M; Briguglio I; Corona P; Piras S; Jabes D; Guglierame P; Molicotti P; Zanetti S Eur J Med Chem; 2011 Jan; 46(1):320-6. PubMed ID: 21145625 [TBL] [Abstract][Full Text] [Related]
18. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens. Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069 [TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone. Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163 [TBL] [Abstract][Full Text] [Related]
20. [Safety profile of antimicrobial agents]. Hori S Yakugaku Zasshi; 2011; 131(10):1423-8. PubMed ID: 21963968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]